Restorative Therapies, Inc
Medical Equipment ManufacturingMaryland, United States51-200 Employees
Restorative Therapies, Inc. develops, manufactures, and supports functional electrical stimulation devices for neurorehabilitation. Its flagship RT300 and Xcite2 systems deliver patient-specific electrical stimulation to help restore movement, improve circulation, and reduce spasticity, addressing secondary complications in individuals with spinal cord injury, stroke, multiple sclerosis, traumatic brain injury, and cerebral palsy. Headquartered in Baltimore, Maryland, and founded in 2004, the company serves rehabilitation hospitals, outpatient clinics, long-term care facilities, and home health providers worldwide. It collaborates with clinicians, researchers, and payers to advance neurorehabilitation and expand access to FES therapy, offering clinical training, reimbursement support, and ongoing customer service. In 2026, the company launched the RT300 FES system and announced its introduction in Korea at KIMES 2026, reflecting ongoing international expansion.